{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:12Z","timestamp":1792839612827,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":1510,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1111\/ajt.15053","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T01:55:29Z","timestamp":1533606929000},"page":"2506-2512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Christine","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Paul Haydek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarouf","family":"Hoteit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela P.","family":"Laurito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Norvell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Terrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Verna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1111\/ajt.15053_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes","volume":"29","author":"Prieto","year":"1999","journal-title":"Hepatology."},{"issue":"13","key":"10.1111\/ajt.15053_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"New Engl J Med."},{"issue":"8","key":"10.1111\/ajt.15053_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/lt.20865","article-title":"Treating hepatitis C infection in liver transplant recipients","volume":"12","author":"Terrault","year":"2006","journal-title":"Liver Transpl."},{"issue":"4","key":"10.1111\/ajt.15053_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology."},{"issue":"7","key":"10.1111\/ajt.15053_bib5","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1600-6143.2006.01362.x","article-title":"Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis","volume":"6","author":"Wang","year":"2006","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1111\/ajt.15053_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/lt.20706","article-title":"Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation","volume":"12","author":"Kontorinis","year":"2006","journal-title":"Liver Transplant."},{"issue":"3","key":"10.1111\/ajt.15053_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.tp.0000196716.07188.c4","article-title":"Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus","volume":"81","author":"Cholongitas","year":"2006","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15053_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?","volume":"56","author":"Berardi","year":"2007","journal-title":"Gut."},{"issue":"5","key":"10.1111\/ajt.15053_bib9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1053\/j.gastro.2012.01.030","article-title":"Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon","volume":"142","author":"Levitsky","year":"2012","journal-title":"Gastroenterology."},{"issue":"21","key":"10.1111\/ajt.15053_bib10","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1056\/NEJMc1611829","article-title":"Perioperative ledipasvir-sofosbuvir for HCV in liver-transplant recipients","volume":"375","author":"Levitsky","year":"2016","journal-title":"New Engl J Med."},{"issue":"3","key":"10.1111\/ajt.15053_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1111\/ajt.15053_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"Charlton","year":"2015","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1111\/ajt.15053_bib13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/TP.0000000000001704","article-title":"International liver transplantation society consensus statement on hepatitis C management in liver transplant recipients","volume":"101","author":"Terrault","year":"2017","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15053_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","article-title":"Acute rejection increases risk of graft failure and death in recent liver transplant recipients","volume":"15","author":"Levitsky","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"12","key":"10.1111\/ajt.15053_bib15","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/lt.21949","article-title":"Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant","volume":"15","author":"Ward","year":"2009","journal-title":"Liver Transpl."},{"issue":"6","key":"10.1111\/ajt.15053_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl."},{"issue":"2","key":"10.1111\/ajt.15053_bib17","first-page":"210","article-title":"Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C","volume":"23","author":"Larrea","year":"1996","journal-title":"Hepatology."},{"issue":"1","key":"10.1111\/ajt.15053_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14218\/JCTH.2016.00001","article-title":"Curing hepatitis C in liver transplant recipients is associated with changes in immunosuppressant use","volume":"4","author":"Saab","year":"2016","journal-title":"J Clin Transl Hepatol."},{"issue":"3","key":"10.1111\/ajt.15053_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J Hepatol."},{"issue":"1","key":"10.1111\/ajt.15053_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology."},{"issue":"11","key":"10.1111\/ajt.15053_bib21","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.cgh.2016.05.016","article-title":"Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents","volume":"14","author":"Perello","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"7","key":"10.1111\/ajt.15053_bib22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3109\/00365521.2016.1157888","article-title":"Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients?","volume":"51","author":"Murunga","year":"2016","journal-title":"Scand J Gastroenterol."},{"issue":"2","key":"10.1111\/ajt.15053_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.path.2018.02.002","article-title":"Chronic hepatitis C and direct acting antivirals","volume":"11","author":"Westerhoff","year":"2018","journal-title":"Surg Pathol Clin."},{"issue":"4","key":"10.1111\/ajt.15053_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/ajt.12667","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O\u2019Leary","year":"2014","journal-title":"Am J Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522097350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522097350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.15053\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:21:51Z","timestamp":1761628911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522097350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1600613522097350"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15053","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}